Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine-prilocaine cream vs Lidocaine injection for contraceptive implant insertion
NCT03187392Phase 3Unknown
- Sponsor
- Assiut University
- Start
- Jun 2017
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of Lidocaine Hydrochloride Injection, without epinephrine and prilocaine in procedural pain (2 arms), sponsored by Assiut University. Primary endpoint: Mean pain score during insertion of implant at 10 minutes. Status: unknown.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrineprilocaine
03
Conditions
procedural pain
Beyond the preview
Go deeper on NCT03187392.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03187392.